cyclosporine has been researched along with Bone Marrow Failure in 7 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 6 (85.71) | 24.3611 |
| 2020's | 1 (14.29) | 2.80 |
| Authors | Studies |
|---|---|
| Doghmi, K; El Maachi, N; El Maaroufi, H; El Mehdi, M; Filali, IA; Jennane, S | 1 |
| Arranto, C; Baldomero, H; Gerull, S; Halter, JP; Heim, D; Kleber, M; Medinger, M; Passweg, JR; Soltermann, Y | 1 |
| Barrett, J; Childs, RW; Cook, L; Donohue, T; Geller, N; Khuu, H; Kurlander, R; Leitman, S; Pantin, J; Ramos, C; Shah, AA; Stroncek, D; Tian, X; Young, NS | 1 |
| Kulasekararaj, AG; Marsh, JC | 1 |
| Risitano, AM | 2 |
| Akahane, D; Asano, N; Ichikawa, N; Kobayashi, H; Sato, K; Shimizu, I; Sumi, M; Ueki, T; Ueno, M; Watanabe, M | 1 |
3 review(s) available for cyclosporine and Bone Marrow Failure
| Article | Year |
|---|---|
Management of the refractory aplastic anemia patient: what are the options?
Topics: Adult; Age Factors; Alemtuzumab; Allografts; Anemia, Aplastic; Antibodies, Monoclonal, Humanized; Antilymphocyte Serum; Antineoplastic Agents; Benzoates; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Disease-Free Survival; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Humans; Hydrazines; Immunosuppression Therapy; Immunosuppressive Agents; Middle Aged; Pyrazoles; Siblings; Survival Rate; Unrelated Donors | 2013 |
Immunosuppressive therapies in the management of immune-mediated marrow failures in adults: where we stand and where we are going.
Topics: Adult; Algorithms; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Hemoglobinuria, Paroxysmal; History, 20th Century; Humans; Immunosuppression Therapy; Immunosuppressive Agents | 2011 |
Immunosuppressive therapies in the management of acquired immune-mediated marrow failures.
Topics: Anemia, Aplastic; Animals; Antilymphocyte Serum; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Hemoglobinuria, Paroxysmal; Horses; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Rabbits | 2012 |
1 trial(s) available for cyclosporine and Bone Marrow Failure
| Article | Year |
|---|---|
Rapid donor T-cell engraftment increases the risk of chronic graft-versus-host disease following salvage allogeneic peripheral blood hematopoietic cell transplantation for bone marrow failure syndromes.
Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Antineoplastic Agents; Bone Marrow Diseases; Bone Marrow Failure Disorders; Child; Chronic Disease; Cyclosporine; Female; Graft Rejection; Graft vs Host Disease; Granulocyte Colony-Stimulating Factor; Hemoglobinuria, Paroxysmal; Humans; Immunosuppressive Agents; Male; Middle Aged; Mycophenolic Acid; Peripheral Blood Stem Cell Transplantation; Risk Factors; Salvage Therapy; T-Lymphocytes; Time Factors; Transplantation Conditioning; Transplantation, Homologous; Vidarabine; Young Adult | 2013 |
3 other study(ies) available for cyclosporine and Bone Marrow Failure
| Article | Year |
|---|---|
[Erythroblastopenia and primary myelofibrosis: a very rare association (a case report)].
Topics: Aged; Bone Marrow; Bone Marrow Failure Disorders; Cyclosporine; Humans; Primary Myelofibrosis; Red-Cell Aplasia, Pure; Spleen; Splenomegaly | 2022 |
Reduced dose of post-transplantation cyclophosphamide compared to ATG for graft-versus-host disease prophylaxis in recipients of mismatched unrelated donor hematopoietic cell transplantation: a single-center study.
Topics: Adult; Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclophosphamide; Cyclosporine; Drug Evaluation; Female; Graft Survival; Graft vs Host Disease; Hematopoietic Stem Cell Transplantation; Hemoglobinuria, Paroxysmal; Histocompatibility; HLA Antigens; Humans; Immunosuppressive Agents; Incidence; Male; Middle Aged; Mycophenolic Acid; Neoplasms; Retrospective Studies; T-Lymphocytes; Tissue Donors | 2019 |
Epstein-Barr virus-associated lymphoproliferative disorder developed after anti-thymocyte globulin therapy in a patient with bone marrow failure associated with T-cell large granular lymphocytic leukemia.
Topics: Aged; Anemia, Aplastic; Antilymphocyte Serum; Bone Marrow; Bone Marrow Diseases; Bone Marrow Failure Disorders; Cyclosporine; Epstein-Barr Virus Infections; Fatal Outcome; Hemoglobinuria, Paroxysmal; Herpesvirus 4, Human; Humans; Immunosuppressive Agents; Leukemia, Large Granular Lymphocytic; Lymphoproliferative Disorders; Male; Multiple Organ Failure | 2011 |